Quantcast
Last updated on April 18, 2014 at 6:46 EDT

Latest Transplantation medicine Stories

2013-07-19 12:24:39

Immunovative Therapies Mirror EffectTM is a unique cancer treatment based on immune system manipulation. Immunovative Therapies says that this treatment creates the tumor-killing effect of bone marrow transplant without the toxic side effects. Immunovative Therapies, using this method, may create a whole new industry of medicine. NEW YORK, July 19, 2013 /PRNewswire-iReach/ -- Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd, a biotech company in Israel, describes a...

2013-07-17 12:26:14

Donor organ allocation policy could be changed to nearly eliminate waitlist mortality for children --without additional risk to adult recipients. BOSTON, July 17, 2013 /PRNewswire-USNewswire/ -- Split liver transplantation carries no increased risk of failure in either recipient, allowing surgeons to safely save two lives from a single donated organ (graft), according to new research from Boston Children's Hospital published online in the Journal of the American College of Surgeons....

2013-07-16 12:27:39

Colorado's largest donation event aims to reach 5,000 participants this year DENVER, July 16, 2013 /PRNewswire/ -- Donor Alliance, the federally designated, non-profit organ procurement organization and American Association of Tissue Banks (AATB) accredited tissue bank serving Colorado and Wyoming will this month once again host the Donor Dash. The 14(th) annual 5K run/walk is to honor the lives of organ and tissue donors, celebrate the lives of organ and tissue recipients and recognize...

2013-07-16 08:30:46

Begins a Ten-Year Partnership with the Phoenix Society CENTENNIAL, Colo., July 16, 2013 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, announced today it pledged an annual financial contribution to the Phoenix Society for Burn Survivors. Working with burn survivors is an important cause to AlloSource. Many...

2013-07-15 23:24:05

Attorney Paul d’Oliveira from the injury law firm of d’Oliveira & Associates has posted a new video so that patients can learn more about Medtronic’s spinal fusion device and its alleged risks. These risks have been reported by medical studies and have now led to Medtronic lawsuits. (PRWEB) July 15, 2013 The Infuse Bone Graft has been on the market since July 2002, but only recently have patients learned about the alleged risks associated with the device. One of the first...

Animal-Human Transplants Work For Diabetes Treatment
2013-07-13 06:31:46

April Flowers for redOrbit.com - Your Universe Online Northwestern Medicine researchers have completed the first step toward animal-human transplants of insulin-producing cells for people with type-1 diabetes by successfully transplanting islets from one species to another. Islets are the cells that produce insulin. The findings of this study, published online in the journal Diabetes, show the islets survived without immunosuppressive drugs. The research team has developed a new method...

2013-07-11 12:28:21

EDISON, N.J., July 11, 2013 /PRNewswire/ -- MTF, the Musculoskeletal Transplant Foundation, announced today that it is the first tissue bank to receive approvals to market human allografts in Australia under the new Australian Biologics Framework, implemented in May 2011. The first two approved biologics in Australia are: DBX® Putty - an osteoinductive bone allograft processed from donated human tissue, specifically designed to meet the Australian medical and regulatory...

2013-07-09 23:23:52

Results demonstrating that a universal stem cell product increases the long-term survival of organ transplants in instances when the cell donor is neither related to the organ donor nor the organ recipient was recently published in STEM CELLS Translational Medicine. The international team of researchers’ approach also appears to alleviate the need for ongoing immune suppression. Durham, NC (PRWEB) July 09, 2013 An international team of researchers published results demonstrating that a...

2013-07-09 08:27:54

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, a biotech company in Israel, discusses a unique approach to cancer treatment, in which its cellular-based drugs stimulate the host immune system to target and kill malignant cells. NEW YORK, July 9, 2013 /PRNewswire-iReach/ -- The most promising way to develop curative treatment that eliminates every cancer cell in a patient, says Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., would be by...

2013-07-05 23:00:52

Parker Waichman LLP is concerned that the public has not been properly educated about the clinically proven potential side effects that could result from Medtronic’s Infuse bone graft product. At the same time, the product continues to be used in ways for which it wasn’t approved, which only heightens the risks of side effects for patients undergoing these procedures. New York, New York (PRWEB) July 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »